Yan R, Fan X, Xiao Z, Liu H, et al. Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/beta-Catenin activity and cancer stemness. Cancer Lett 2022;531:83-97.
PMID: 35157971